Why this meeting matters
In early December 2015, IUCN quietly convened three dozen people at the Rockefeller Foundation’s Bellagio Center to ask a blunt question: What does synthetic biology mean for biodiversity politics?
The meeting, titled “Biodiversity Conservation in the Context of Synthetic Biology,” ran from 1 to 5 December and produced a detailed report in March 2016. It framed synthetic biology as both a potential tool and a potential threat: something that might help with habitat restoration, invasive species, disease, and overharvest, but that could just as easily deepen existing crises if left to corporate or technophile agendas.
“It is thus necessary to consider how IUCN might lead global conservation on matters related to this new conservation tool.”
Who was in the room
The participant list reads like a cross‑section of the emerging debate: conservation biologists from IUCN’s Species Survival Commission, ethicists, environmental lawyers, synthetic biologists, and policy people from organizations like the J. Craig Venter Institute. The commissions represented included Environmental, Economic and Social Policy; Education and Communication; Environmental Law; and Ecosystem Management.
The framing statement admits, in unusually direct language, that the conservation community was “ill‑prepared” for the speed and scope of synthetic biology. IUCN positions itself as a hub that could connect field biologists, global treaties, and researchers working on gene drives, engineered microbes, and bio‑based commodities.
What they were trying to decide
The Bellagio agenda is structured around three big questions:
- How could synthetic biology be made beneficial to conservation, sustainable development, and human livelihoods?
- What unexpected impacts might it have, and how could these be mitigated?
- Under what circumstances should it not be used in conservation at all?
From there, the group set explicit goals: to spell out why synthetic biology matters to IUCN’s mission, to identify five ways it could help and five ways it could clash with conservation, and to sketch how IUCN should try to influence the field while it is “still susceptible to change.”
This was not a technical workshop; it was an attempt to draw political lines around a fast‑moving technology before those lines were set elsewhere.
Substitution, overharvest, and the rhino‑horn question
One working group was tasked with “habitat loss and unsustainable use,” and within that, with overharvest. Their notes go straight to examples that look uncomfortably close to wildlife biofabrication: engineered production of compounds currently sourced from endangered plants and animals, and the idea of using synthetic biology to stand in for wild harvest.
They list cases where synthetic production might ease pressure:
- A cancer drug precursor (from Himalayan mayapple) synthesised in tobacco to reduce wild harvest.
- Improved aquaculture and protein production to reduce fishing pressure.
- Industrial production of compounds like squalene to avoid deep‑sea shark exploitation.
Right next to those, they park a set of warnings that read like an early institutional response to “lab‑grown” wildlife products:
- Synthetic biology substitutes for rhino horn or bear bile, risking opening legal markets that are currently closed, allowing the laundering of illegal products.
- There is a danger of “unwittingly expanding demand,” especially where the wild‑sourced version is seen as higher status or more potent.
- They flag Veblen dynamics directly: for goods where a higher price signals prestige, improved supply can feed the market rather than calm it.
“Look at the risk of unwittingly expanding demand… Veblen goods: increasing price increases demand.”
The notes also mention the idea of making horn on other animals (“rhino horns on cows”) or breeding hornless rhinos as part of a broader overharvest section, but the concern is the same: once synthetic biology enters a luxury wildlife market, conservationists lose control over how the signal is read.
The Bellagio group does not reject substitution outright, but it treats claims that “synthetic horn will save rhinos” as unproven, high‑risk bets that could just as easily entrench demand.
Governance and moral hazard
Beyond substitution, the report circles through a catalog of worries that were already familiar from other biotech fights: runaway spread of modified organisms, corporate control, black markets, and the temptation to treat technological fixes as excuses not to change behavior.
One exercise on the global conservation community concerns lists:
- The fear that de‑extinction and other dramatic interventions create a moral hazard: if extinction is seen as reversible, the urgency to pursue preventive conservation drains.
- The risk is that technological fixes become “silver bullets” that crowd out work on the underlying drivers, such as land use and consumption.
- Uneven power: private actors owning tools that shape ecosystems across borders, while affected communities have little say.
Their proposed responses are mostly procedural: better risk‑assessment frameworks, codes of conduct, and the use of existing conventions rather than inventing wholly new ones. There is a repeated insistence on involving local stakeholders early, particularly Indigenous communities in places like Hawai‘i, where proposals for gene‑drive mosquitoes intersect with long histories of contested GMO projects.
How it fed into policy
The last third of the report is housekeeping and strategy: which congresses to attend, what papers to write, how to update IUCN’s older GMO resolutions, how to brief the Convention on Biological Diversity and the UN system. It calls for:
- A draft resolution on synthetic biology for the 2016 IUCN World Conservation Congress.
- An opinion piece in a journal like Trends in Ecology & Evolution to set out early principles.
- Work towards guidelines and, eventually, a consolidated IUCN policy on synthetic biology and conservation.
In hindsight, Bellagio reads as the moment when synthetic biology stopped being a curiosity at the edges of conservation and became something institutions had to get ahead of.
For anyone trying to understand how mainstream conservation bodies came to adopt a cautious, case‑by‑case stance on issues like gene drives and synthetic wildlife products, this meeting report is the hinge document. It doesn’t settle the arguments, but it shows who was arguing, what they feared most, and which risks they were willing to contemplate in the name of conservation.
